Shanghai ZJ Bio-Tech Co

Shanghai ZJ Bio-Tech Co Intangible Assets

The Intangible Assets of Shanghai ZJ Bio-Tech Co (688317.SS) as of Oct 31, 2026 is 7.80 M CNY. In the previous year, Intangible Assets was 6.06 M CNY — a change of 28.73% (higher).

Intangible Assets

7.80 MCNY

YoY

28.73%

Last updated:

Intangible Assets of Shanghai ZJ Bio-Tech Co is 2024 7.80 M CNY. Intangible Assets of Shanghai ZJ Bio-Tech Co was 2023 6.06 M CNY. It decreases by 28.73% higher compared to the previous year.

The Shanghai ZJ Bio-Tech Co Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
500,000.00 CNY
Jan 1, 2018
1.00 M CNY
Jan 1, 2019
1.10 M CNY
Jan 1, 2020
3.70 M CNY
Jan 1, 2021
6.57 M CNY
Jan 1, 2022
6.84 M CNY
Jan 1, 2023
6.06 M CNY
Jan 1, 2024
7.80 M CNY
The Shanghai ZJ Bio-Tech Co Intangible Assets history
YEARIntangible AssetsYoY
7.80 MCNY+28.73%
6.06 MCNY-11.39%
6.84 MCNY+4.14%
6.57 MCNY+77.49%
3.70 MCNY+236.36%
1.10 MCNY+10.00%
1.00 MCNY+100.00%
500,000.00CNY-16.67%
600,000.00CNY+20.00%
500,000.00CNY0.00%
500,000.00CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai ZJ Bio-Tech Co Stock analysis

What does Shanghai ZJ Bio-Tech Co do? Shanghai ZJ Bio-Tech Co., Ltd. generates revenue through the research, development, production, and sale of molecular diagnostic reagents and instruments. The company's primary products are nucleic acid detection kits and molecular diagnostic instruments, which are sold to customers in sectors including emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The firm focuses its business activities within the domestic market, targeting institutions and organizations requiring diagnostic solutions for public health and clinical applications. The company's business model centers on providing diagnostic reagents and equipment for critical applications such as emergency public health safety and medical clinical diagnosis. Its products are designed to meet the needs of domestic customers in healthcare, public safety, and food safety sectors, with a strong emphasis on molecular diagnostics. Shanghai ZJ Bio-Tech leverages its domestic market presence to serve institutions requiring reliable diagnostic tools for health and safety monitoring. Shanghai ZJ Bio-Tech Co., Ltd. operates with a domestic market focus, selling its molecular diagnostic instruments and reagents to entities involved in public health, clinical diagnosis, and food safety. The firm's revenue streams are derived from the sale of nucleic acid detection kits and molecular diagnostic instruments, which are essential for applications in emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. Shanghai ZJ Bio-Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai ZJ Bio-Tech Co stock

Intangible Assets of Shanghai ZJ Bio-Tech Co is 7.80 M CNY in 2024.

Intangible Assets of Shanghai ZJ Bio-Tech Co changed from 6.06 M CNY to 7.80 M CNY, representing a 28.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Shanghai ZJ Bio-Tech Co since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Shanghai ZJ Bio-Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Shanghai ZJ Bio-Tech Co

All Key Metrics — Shanghai ZJ Bio-Tech Co